Back to Search Start Over

Treatment of post-cholecystectomy biliary strictures with fully-covered self-expanding metal stents - results after 5 years of follow-up

Authors :
Tringali, A. (A.)
Reddy, D.N. (D. Nageshwar)
Ponchon, T. (Thierry)
Neuhaus, H. (Horst)
Lladó, F.G.-H. (Ferrán González-Huix)
Navarrete, C.
Bruno, M.J. (Marco)
Kortan, P.P. (Paul)
Lakhtakia, S. (S.)
Peetermans, J. (Joyce)
Rousseau, M. (Matthew)
Carr-Locke, D. (David)
Devière, J. (J.)
Costamagna, G. (Guido)
Tringali, A. (A.)
Reddy, D.N. (D. Nageshwar)
Ponchon, T. (Thierry)
Neuhaus, H. (Horst)
Lladó, F.G.-H. (Ferrán González-Huix)
Navarrete, C.
Bruno, M.J. (Marco)
Kortan, P.P. (Paul)
Lakhtakia, S. (S.)
Peetermans, J. (Joyce)
Rousseau, M. (Matthew)
Carr-Locke, D. (David)
Devière, J. (J.)
Costamagna, G. (Guido)
Publication Year :
2019

Abstract

BACKGROUND: Endoscopic treatment of post-cholecystectomy biliary strictures (PCBS) with multiple plastic biliary stents placed sequentially is a minimally invasive alternative to surgery but requires multiple interventions. Temporary placement of a single fully-covered self-expanding metal stent (FCSEMS) may offer safe and effective treatment with fewer re-interventions. Long-term effectiveness of treatment with FCSEMS to obtain PCBS resolution has not yet been studied. METHODS: In this prospective multi-national study in patients with symptomatic benign biliary strictures (N = 187) due to various etiologies received a FCSEMS with scheduled removal at 6-12 months and were followed for 5 years. We report here long-term outcomes of the subgroup of patients with PCBS (N = 18). Kaplan Meier analyses assessed long-term freedom from re-stenting. Adverse events were documented. RESULTS: Endoscopic removal of the FCSEMS was achieved in 83.3% (15/18) of patients after median indwell of 10.9 (range 0.9-13.8) months. In the remaining 3 patients (16.7%), the FCSEMS spontaneously migrated and passed without complications. At the end of FCSEMS indwell, 72% (13/18) of patients had stricture resolution. At 5 years after FCSEMS removal, 84.6% (95% CI 65.0-100.0%) of patients who had stricture resolution at FCSEMS removal remained stent-free. In addition, at 75 months after FCSEMS placement, the probability of remaining stent-free was 61.1% (95% CI 38.6-83.6%) for all patients. Stent or removal related serious adverse events occurred in 38.9% (7/18) all resolved without sequalae. CONCLUSIONS: In patients with symptomatic PCBS, temporary placement of a single FCSEMS intended for 10-12 months indwell is associated with long-term stricture resolution up to 5 years. Temporary placement of a single FCSEMS may be considered for patients with PCBS not involving the main hepatic confluence. TRIAL REGISTRATION NUMBERS: NCT01014390; CTRI/2012/12/003166; Registered 17 November 2009.

Details

Database :
OAIster
Notes :
application/pdf, B M C Gastroenterology vol. 19 no. 1, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1143371648
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1186.s12876-019-1129-3